Evan Gleaves
Bowling Green, KYNPI 1477181246
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,342 of the $4,147 with a category attached, or 80.6%. 29 manufacturers reported payments, led by Abiomed at 28.9% of the total. 2025 is the largest year on record at $2,394, more than ten times the $13 reported in 2021.
Across 139 payments — averaging $29.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$1K
- Medtronic$617
- Pfizer$271
- Abbott$264
- Heartflow, Inc.$205
- Merck$160
- plus $1K from 23 others
What the payments were for
- Travel & lodging$55813%
- Food & beverage$3,34281%
- Education$2466%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 37 | $1,200 |
| Medtronic | 2 | $617 |
| Pfizer | 16 | $271 |
| Abbott | 2 | $264 |
| Heartflow, Inc. | 5 | $205 |
| Merck | 7 | $160 |
| Boehringer Ingelheim | 1 | $151 |
| Johnson & Johnson | 10 | $131 |
| Alnylam Pharmaceuticals Inc. | 6 | $123 |
| Chiesi USA, Inc. | 5 | $122 |
| Actelion Pharmaceuticals US, Inc. | 5 | $104 |
| Grifols USA, LLC | 6 | $101 |
| AstraZeneca | 5 | $87 |
| Verona Pharma, Inc. | 5 | $86 |
| La Jolla Pharmaceutical Company | 3 | $75 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $64 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| Stryker | 1 | $49 |
| Bayer | 3 | $47 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $40 |
| Philips North America LLC | 2 | $31 |
| Edwards Lifesciences | 1 | $25 |
| Shockwave Medical, Inc | 1 | $25 |
| Vifor Pharma, Inc. | 1 | $25 |
| United Therapeutics Corporation | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| CSL Behring | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.